Blue Biofuels, Inc. reported a net loss of $2.87 million for the fiscal year ending December 31, 2025, compared to a net loss of $1.42 million in 2024. The increase in losses was primarily due to the absence of revenue, as the company has not generated material income from its core operations, although it recognized $865,000 in grant income from a Department of Energy grant. The company's total operating expenses decreased to $3.72 million from $4.06 million in the previous year, attributed to lower stock-based compensation and professional fees.
The company has made significant strides in its operational capabilities, including the completion of a pilot plant and the optimization of its Cellulose-to-Sugar (CTS) process. In January 2024, Blue Biofuels formed a joint venture with Vertimass, named VertiBlue Fuels, LLC, aimed at constructing an ethanol-to-sustainable aviation fuel (SAF) facility in Florida. This facility is projected to produce between 10 to 25 million gallons of SAF initially, with plans to expand production to approximately 70 million gallons annually. The joint venture is expected to leverage the company's patented CTS technology for future production.
As of December 31, 2025, Blue Biofuels had a total of 317.87 million shares of common stock outstanding, with a stockholders' deficit of $3.71 million. The company employed six full-time employees and one part-time employee, with plans to expand its workforce to accelerate the commercialization of its technology. The company’s cash position improved slightly to $65,200 from $48,797 in 2024, but it continues to face liquidity challenges, with total current liabilities increasing to $2.98 million.
Looking ahead, Blue Biofuels anticipates needing approximately $90 million to fund its share of the VertiBlue Fuels joint venture and to commence commercial production of SAF. The company plans to raise this capital through project financing and expects to generate revenue from the joint venture within 18 to 24 months after securing the necessary funding. However, the company has expressed uncertainty regarding its ability to continue as a going concern, given its accumulated losses of $60.13 million since inception and the need for additional financing to sustain operations.
In summary, while Blue Biofuels has made progress in developing its technology and forming strategic partnerships, it continues to face significant financial challenges and must secure additional funding to achieve its operational goals and ensure its long-term viability.
About BLUE BIOFUELS, INC.
Blue Biofuels, Inc. develops patented renewable energy technologies focused on converting cellulosic biomass into fermentable sugars via its Cellulose-to-Sugar (CTS) process. These sugars serve as feedstock for producing cellulosic ethanol, sustainable aviation fuel (SAF), and other biofuels. The company targets biofuel producers and leverages modular, mechanical-chemical systems with broad feedstock flexibility, aiming to capitalize on government renewable fuel credits and incentives in the U.S. and international markets.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.